- Market Realist•1 hour ago
Analysts expect a fall of ~0.6% in Novartis’s (NVS) 3Q16 revenue to $12.2 billion following the effects of its product acquisitions and divestitures.
- Market Realist•4 hours ago
Novartis, one of the world's largest pharmaceutical companies by revenue, is set to release its 3Q16 earnings on October 25, 2016.
Novartis AG (NVS)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||74.81 x 100|
|Ask||76.48 x 100|
|Day's Range||75.05 - 75.61|
|52wk Range||69.90 - 93.58|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||26.97|
|Avg Vol (3m)||1,616,586|
|Dividend & Yield||2.72 (3.59%)|